Abstract
While the use of medicinal leech therapy (MLT) in reconstructive and orthopaedic surgery is widely described, post-operative complications related to leeches remain a major concern. Aeromonas spp. strains are involved in the majority of reported cases. As surgical success rate is directly impacted, an adapted antibiotic prophylaxis should be instituted in order to minimize these complications. We assessed pharmaceutical process, microbiological control and related infections in order to provide data and choose the appropriate antibiotherapy for patients requiring MLT. We report a clinical and microbiological study over a 24-month period. Clinical data were collected from patients’ database, and microbiological analysis both on leeches’ tank water and crushed leeches were performed to characterize isolated strains and their susceptibility to antibiotics. A total of 595 leeches were used to treat 28 patients (12 in plastic surgery and 16 in orthopaedic surgery), and three documented cases of post-operative infections were reported. Aeromonas spp. isolates yielded from 62 % of analyzed batches (75 % of Aeromonas veronii). Eighteen Aeromonas spp. isolates yielded from 23 water samples and three crushed leeches. Isolates were similar in tank and crushed leeches. Strains were susceptible to fluoroquinolones, sulfamethoxazole/trimethoprim, aminosides, and third-generation cephalosporins but resistant to amoxicillin/clavulanic acid and second-generation cephalosporins. According to collected data, routine tank water microbiological analyses are mandatory in order to identify leeches’ batches containing resistant strains and to discard them. In this context, the surgeon is able to select an appropriated antibiotic prophylaxis in order to avoid MLT associated serious post-operative complications.
Similar content being viewed by others
References
Whitaker IS, Rao J, Izadi D, Butler PE (2004) Historical article: Hirudo medicinalis: ancient origins of, and trends in the use of medicinal leeches throughout history. Br J Oral Maxillofac Surg 42:133–137
Mory RN, Mindell D, Bloom DA (2000) The leech and the physician: biology, etymology, and medical practice with Hirudinea medicinalis. World J Surg 24:878–883
Rados C (2004) Beyond bloodletting: FDA gives leeches a medical makeover. FDA Consum 38:9
Derganc M, Zdravic F (1960) Venous congestion of flaps treated by application of leeches. Br J Plast Surg 13:187–192
Whitaker IS, Oboumarzouk O, Rozen WM, Naderi N, Balasubramanian SP, Azzopardi EA, Kon M (2012) The efficacy of medicinal leeches in plastic and reconstructive surgery: a systematic review of 277 reported clinical cases. Microsurgery 32:240–250
Whitaker IS, Izadi D, Oliver DW, Monteath G, Butler PE (2004) Hirudo medicinalis and the plastic surgeon. Br J Plast Surg 57:348–353
Michalsen A, Klotz S, Lüdtke R, Moebus S, Spahn G, Dobos GJ (2003) Effectiveness of leech therapy in osteoarthritis of the knee: a randomized, controlled trial. Ann Intern Med 139:724–730
Michalsen A, Moebus S, Spahn G, Esch T, Langhorst J, Dobos GJ (2002) Leech therapy for symptomatic treatment of knee osteoarthritis: results and implications of a pilot study. Altern Ther Health Med 8:84–88
Michalsen A, Lüdtke R, Cesur O, Afra D, Musial F, Baecker M, Fink M, Dobos GJ (2008) Effectiveness of leech therapy in women with symptomatic arthrosis of the first carpometacarpal joint: a randomized controlled trial. Pain 137:452–459
Whitaker IS, Cheung CK, Chahal CAA, Karoo ROS, Gulati A, Foo ITH (2005) By what mechanism do leeches help to salvage ischaemic tissues? a review. Br J Oral Maxillofac Surg 43:155–160
Whitaker IS, Maltz M, Siddall ME, Graf J (2014) Characterization of the digestive tract microbiota of Hirudo orientalis (medicinal leech) and antibiotic resistance profile. Plast Reconstr Surg 133:408e–418e
Whitaker IS, Kamya C, Azzopardi EA, Graf J, Kon M, Lineaweaver WC (2009) Preventing infective complications following leech therapy: is practice keeping pace with current research? Microsurgery 29:619–625
Whitaker IS, Elmiyeh B, Wright DJ (2003) Hirudo medicinalis: the need for prophylactic antibiotics. Plast Reconstr Surg 112:1185–1186
Bauters TGM, Buyle FMA, Verschraegen G, Vermis K, Vogelaers D, Claeys G, Robays H (2007) Infection risk related to the use of medicinal leeches. Pharm World Sci 29:122–125
Sartor C, Limouzin-Perotti F, Legré R, Casanova D, Bongrand M-C, Sambuc R, Drancourt M (2002) Nosocomial Infections with Aeromonas hydrophila from Leeches. Clin Infect Dis 35:E1–5
Sartor C, Bornet C, Guinard D, Fournier P-E (2013) Transmission of Aeromonas hydrophila by leeches. Lancet 381:1686
Schnabl SM, Kunz C, Unglaub F, Polykandriotis E, Horch RE, Dragu A (2010) Acute postoperative infection with Aeromonas hydrophila after using medical leeches for treatment of venous congestion. Arch Orthop Trauma Surg 130:1323–1328
Lineaweaver WC, Hill MK, Buncke GM, Follansbee S, Buncke HJ, Wong RK, Manders EK, Grotting JC, Anthony J, Mathes SJ (1992) Aeromonas hydrophila infections following use of medicinal leeches in replantation and flap surgery. Ann Plast Surg 29:238–244
Lineaweaver WC (1991) Aeromonas hydrophila infections following clinical use of medicinal leeches: a review of published cases. Blood Coagul Fibrinolysis 2:201–203
Whitaker IS, Josty IC, Hawkins S, Azzopardi E, Naderi N, Graf J, Damaris L, Lineaweaver WC, Kon M (2011) Medicinal leeches and the microsurgeon: a four-year study, clinical series and risk benefit review. Microsurgery 31:281–287
Eroglu C, Hokelek M, Guneren E, Esen S, Pekbay A, Uysal OA (2001) Bacterial flora of Hirudo medicinalis and their antibiotic sensitivities in the Middle Black Sea Region, Turkey. Ann Plast Surg 47:70–73
de Chalain TM (1996) Exploring the use of the medicinal leech: a clinical risk-benefit analysis. J Reconstr Microsurg 12:165–172
Mumcuoglu KY, Huberman L, Cohen R, Temper V, Adler A, Galun R, Block C (2010) Elimination of symbiotic Aeromonas spp. from the intestinal tract of the medicinal leech, Hirudo medicinalis, using ciprofloxacin feeding. Clin Microbiol Infect 16:563–567
Aydin A, Nazik H, Kuvat SV, Gurler N, Ongen B, Tuncer S, Hocaoglu E, Kesim SN (2004) External decontamination of wild leeches with hypochloric acid. BMC Infect Dis 4:28
Graf J, Kikuchi Y, Rio RVM (2006) Leeches and their microbiota: naturally simple symbiosis models. Trends Microbiol 14:365–371
Snower DP, Ruef C, Kuritza AP, Edberg SC (1989) Aeromonas hydrophila infection associated with the use of medicinal leeches. J Clin Microbiol 27:1421–1422
Wang EW, Warren DK, Ferris VM, Casabar E, Nussenbaum B (2011) Leech-transmitted ciprofloxacin-resistant Aeromonas hydrophila. Arch Otolaryngol Head Neck Surg 137:190–193
Kruer RM, Barton CA, Roberti G, Gilbert B, McMillian WD (2015) Antimicrobial prophylaxis during Hirudo medicinalis therapy: a multicenter study. J Reconstr Microsurg 31:205–209
Lamy B, Kodjo A, Laurent F (2009) Prospective nationwide study of Aeromonas infections in France. J Clin Microbiol 47:1234–1237
Hermansdorfer J, Lineaweaver W, Follansbee S, Valauri FA, Buncke HJ (1988) Antibiotic sensitivities of Aeromonas hydrophila cultured from medicinal leeches. Br J Plast Surg 41:649–651
Bibbo C, Fritsche T, Stemper M, Hall M (2013) Flap infection associated with medicinal leeches in reconstructive surgery: two new drug-resistant organisms. J Reconstr Microsurg 29:457–460
Giltner CL, Bobenchik AM, Uslan DZ, Deville JG, Humphries RM (2013) Ciprofloxacin-resistant Aeromonas hydrophila cellulitis following leech therapy. J Clin Microbiol 51:1324–1326
van Alphen NA, Gonzalez A, McKenna MC, McKenna TK, Carlsen BT, Moran SL (2014) Ciprofloxacin-resistant Aeromonas infection following leech therapy for digit replantation: report of 2 cases. J Hand Surg [Am] 39:499–502
European Committee on Antimicrobial Susceptibility Testing (2013) Breakpoint tables for interpretation of MICs and zone diameters, version 3.1. EUCAST
Silver AC, Kikuchi Y, Fadl AA, Sha J, Chopra AK, Graf J (2007) Interaction between innate immune cells and a bacterial type III secretion system in mutualistic and pathogenic associations. Proc Natl Acad Sci USA 104:9481–9486
Yu HB, Zhang YL, Lau YL, Yao F, Vilches S, Merino S, Tomas JM, Howard SP, Leung KY (2005) Identification and characterization of putative virulence genes and gene clusters in Aeromonas hydrophila PPD134/91. Appl Environ Microbiol 71:4469–4477
Silver AC, Rabinowitz NM, Küffer S, Graf J (2007) Identification of Aeromonas veronii genes required for colonization of the medicinal leech, Hirudo verbana. J Bacteriol 189:6763–6772
Alcaide E, Blasco M-D, Esteve C (2010) Mechanisms of quinolone resistance in Aeromonas species isolated from humans, water and eels. Res Microbiol 161:40–45
Arias A, Seral C, Gude MJ, Castillo FJ (2010) Molecular mechanisms of quinolone resistance in clinical isolates of Aeromonas caviae and Aeromonas veronii bv. sobria. Int Microbiol 13:135–141
Cattoir V, Poirel L, Aubert C, Soussy C-J, Nordmann P (2008) Unexpected occurrence of plasmid-mediated quinolone resistance determinants in environmental Aeromonas spp. Emerg Infect Dis 14:231–237
Hueck CJ (1998) Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 62:379–433
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
This study was self-funded by the pharmacy and microbiology department, and the authors declare that they have no conflict of interest.
Research involving Human Participants and/or Animals
For retrospective studies formal consent is not required. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. Informed consent is not applicable (retrospective study).
Rights and permissions
About this article
Cite this article
Verriere, B., Sabatier, B., Carbonnelle, E. et al. Medicinal leech therapy and Aeromonas spp. infection. Eur J Clin Microbiol Infect Dis 35, 1001–1006 (2016). https://doi.org/10.1007/s10096-016-2629-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-016-2629-5